EA
ARRY

Emerald Acquisition’s Array Biopharma Inc ARRY Stock Holding History

Emerald Acquisition’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$834K Buy
+123,502
New +$478K ﹤0.01% 2221

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Emerald Acquisition's ARRY Position: Q3 2016 in Review

Emerald Acquisition opened a new position in Array Biopharma Inc (ARRY) in Q3 2016: 123,502 shares worth $834K. The stake represents ﹤0.01% of the portfolio and ranks #2221 among its holdings.

169 funds tracked by Wall St. Rank hold ARRY as of Q3 2016.

  • Emerald Acquisition held 123,502 shares of Array Biopharma Inc worth $834K as of Q3 2016.
  • Array Biopharma Inc was a new Emerald Acquisition position in Q3 2016.
  • Array Biopharma Inc made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2221 holding.
  • 169 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.